A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetes Mellitus

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

T2DM

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, China
Contact: Study coordinator (Hongwei Jiang, Professor) · jianghw@haust.edu.cn · 0379-69823582

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 1b Study of QX1206 in T2DM Patients With NAFLD

Type 2 Diabetes Mellitus (T2DM) · Non-Alcoholic Fatty Liver Disease (NAFLD)

Abroad (travel likely)RecruitingPHASE1

Toronto, Canada

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus · T2DM

Abroad (travel likely)RecruitingPHASE2

Mesa, United States · Orlando, United States

CGM for Management of Type 2 Diabetes in Pregnancy

Type 2 Diabetes Mellitus (T2DM) · Pregnancy

Abroad (travel likely)Recruiting

Birmingham, United States · San Diego, United States

Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD

Type 2 Diabetes Mellitus (T2DM) · MASH - Metabolic Dysfunction-Associated Steatohepatitis · Metabolic Dysfunction-associated Fatty Liver Disease

Abroad (travel likely)Recruiting

Bengbu, China · Hefei, China